Index RUT
P/E -
EPS (ttm) -3.39
Insider Own 3.62%
Shs Outstand 49.43M
Perf Week 11.56%
Market Cap 410.28M
Forward P/E -
EPS next Y -1.03
Insider Trans -11.73%
Shs Float 47.64M
Perf Month 7.37%
Income -166.47M
PEG -
EPS next Q -0.28
Inst Own 95.50%
Short Float 5.66%
Perf Quarter 6.55%
Sales 226.11M
P/S 1.81
EPS this Y -6.79%
Inst Trans -5.48%
Short Ratio 6.11
Perf Half Y -21.85%
Book/sh 7.81
P/B 1.06
EPS next Y 56.25%
ROA -18.62%
Short Interest 2.70M
Perf Year -45.50%
Cash/sh 5.52
P/C 1.50
EPS next 5Y -
ROE -33.15%
52W Range 5.32 - 20.10
Perf YTD -46.42%
Dividend Est. -
P/FCF -
EPS past 5Y -45.48%
ROI -26.37%
52W High -58.72%
Beta 1.61
Dividend TTM -
Quick Ratio 5.32
Sales past 5Y 78.51%
Gross Margin 34.51%
52W Low 56.16%
ATR (14) 0.57
Dividend Ex-Date -
Current Ratio 5.70
EPS Y/Y TTM -201.68%
Oper. Margin -31.65%
RSI (14) 62.73
Volatility 8.59% 7.72%
Employees 1170
Debt/Eq 0.56
Sales Y/Y TTM -4.33%
Profit Margin -73.62%
Recom 2.33
Target Price 10.88
Option/Short Yes / Yes
LT Debt/Eq 0.51
EPS Q/Q 92.25%
Payout -
Rel Volume 1.16
Prev Close 8.33
Sales Surprise -2.40%
EPS Surprise 93.53%
Sales Q/Q 0.90%
Earnings Nov 07 AMC
Avg Volume 441.33K
Price 8.30
SMA20 14.31%
SMA50 13.07%
SMA200 -21.81%
Trades
Volume 511,355
Change -0.36%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-07-24 Downgrade
Jefferies
Buy → Hold
$20 → $8
Jul-31-24 Upgrade
B. Riley Securities
Neutral → Buy
$19 → $15
May-03-24 Downgrade
B. Riley Securities
Buy → Neutral
$22 → $19
Apr-04-24 Resumed
Jefferies
Buy
$17 → $21
Mar-13-24 Reiterated
Needham
Buy
$19 → $18
Aug-17-23 Initiated
Morgan Stanley
Equal-Weight
$16
Aug-10-23 Downgrade
Stephens
Overweight → Equal-Weight
$15
Jul-18-23 Downgrade
UBS
Buy → Neutral
$28 → $17
Jul-17-23 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jul-13-23 Downgrade
SVB Securities
Outperform → Market Perform
$30 → $10
Jan-19-22 Upgrade
ROTH Capital
Neutral → Buy
$90
Nov-05-21 Downgrade
ROTH Capital
Buy → Neutral
$78 → $90
Oct-19-21 Resumed
B. Riley Securities
Buy
$81
Jul-16-21 Initiated
BTIG Research
Buy
$80
Mar-15-21 Initiated
UBS
Buy
$84
Mar-02-21 Resumed
Needham
Buy
$73
Nov-10-20 Initiated
KeyBanc Capital Markets
Overweight
$54
Jan-08-20 Initiated
Stephens
Overweight
$21
Jul-01-19 Resumed
Needham
Buy
$22
Oct-10-18 Initiated
B. Riley FBR
Buy
$22
Show Previous Ratings
Nov-12-24 08:30AM
Nov-08-24 04:03PM
Nov-07-24 05:55PM
04:05PM
Nov-06-24 07:37AM
10:01AM
Loading…
Oct-31-24 10:01AM
Oct-29-24 08:30AM
Oct-22-24 08:30AM
Oct-21-24 08:30AM
Oct-15-24 08:30AM
Oct-07-24 08:30AM
Sep-25-24 08:30AM
Sep-09-24 05:28AM
Aug-19-24 03:27AM
Aug-06-24 07:00PM
04:15PM
Loading…
04:15PM
04:05PM
Jul-23-24 08:30AM
Jul-12-24 02:46AM
Jul-09-24 09:35AM
Jun-20-24 08:30AM
May-17-24 02:33AM
May-08-24 02:54PM
04:03AM
May-07-24 09:56PM
06:18PM
04:08PM
May-03-24 10:12AM
06:41AM
Apr-30-24 08:30AM
10:02AM
Loading…
Apr-25-24 10:02AM
Mar-13-24 09:16AM
Mar-12-24 05:52PM
05:30PM
04:05PM
Feb-27-24 08:30AM
Feb-15-24 10:00AM
Feb-13-24 09:55AM
Nov-27-23 08:30AM
Nov-21-23 03:26PM
Nov-16-23 08:30AM
Nov-09-23 05:23PM
Nov-08-23 06:05PM
04:05PM
Nov-02-23 08:30AM
Oct-26-23 10:02AM
Oct-25-23 08:30AM
Oct-12-23 08:30AM
Oct-10-23 08:30AM
Oct-09-23 04:05PM
Sep-14-23 08:30AM
Aug-10-23 07:14AM
Aug-09-23 05:30PM
04:05PM
Aug-02-23 08:30AM
Jul-31-23 08:53AM
Jul-23-23 08:17AM
Jul-13-23 12:24PM
11:17AM
Jul-12-23 04:05PM
12:56PM
Jun-29-23 08:39AM
May-25-23 08:02AM
May-12-23 07:15AM
May-04-23 06:05PM
04:05PM
Apr-27-23 10:02AM
08:30AM
Apr-25-23 08:30AM
Apr-01-23 08:54AM
Mar-28-23 08:30AM
Mar-16-23 03:46AM
Mar-13-23 06:00AM
Mar-08-23 01:15PM
Feb-23-23 06:40PM
04:05PM
Feb-15-23 08:30AM
Jan-29-23 07:31AM
Jan-26-23 10:55AM
Jan-18-23 08:30AM
Dec-20-22 08:30AM
Dec-19-22 07:15AM
Nov-08-22 06:56AM
Nov-07-22 08:10PM
05:03AM
Nov-03-22 06:45PM
04:05PM
Oct-27-22 08:30AM
05:32AM
Sep-08-22 08:30AM
Aug-08-22 02:42PM
(Investor's Business Daily) +6.83%
Aug-06-22 10:18AM
Aug-05-22 09:55AM
Aug-04-22 07:15PM
04:05PM
Jul-28-22 08:30AM
Jul-01-22 08:57AM
May-05-22 07:05PM
04:05PM
Apr-28-22 08:30AM
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mandalam Ramkumar Director Dec 02 '24 Option Exercise 4.80 10,834 52,003 66,866 Dec 04 07:00 PM Mandalam Ramkumar Director Dec 02 '24 Sale 7.46 7,369 54,978 59,497 Dec 04 07:00 PM Hariri Robert J Director Nov 21 '24 Sale 6.48 2,500 16,200 20,561 Dec 02 07:00 PM RAMKUMAR MANDALAM Director Dec 02 '24 Proposed Sale 7.08 7,369 52,173 Dec 02 04:43 PM SHELTON JERRELL President, CEO Nov 21 '24 Option Exercise 4.80 59,150 283,920 781,897 Nov 25 07:00 PM SHELTON JERRELL President, CEO Nov 22 '24 Option Exercise 4.80 26,862 128,938 758,759 Nov 25 07:00 PM SHELTON JERRELL President, CEO Nov 21 '24 Sale 6.51 50,000 325,275 731,897 Nov 25 07:00 PM SHELTON JERRELL President, CEO Nov 22 '24 Sale 6.47 22,817 147,612 735,942 Nov 25 07:00 PM JERRELL W SHELTON Director Nov 22 '24 Proposed Sale 6.52 22,817 148,767 Nov 22 04:31 PM SHELTON JERRELL President, CEO Nov 19 '24 Option Exercise 4.80 60,440 290,112 762,747 Nov 20 07:57 PM SHELTON JERRELL President, CEO Nov 18 '24 Option Exercise 4.80 60,215 289,032 752,307 Nov 20 07:57 PM SHELTON JERRELL President, CEO Nov 20 '24 Option Exercise 4.80 60,000 288,000 772,747 Nov 20 07:57 PM SHELTON JERRELL President, CEO Nov 19 '24 Sale 6.78 50,000 338,985 712,747 Nov 20 07:57 PM SHELTON JERRELL President, CEO Nov 18 '24 Sale 6.73 50,000 336,540 702,307 Nov 20 07:57 PM SHELTON JERRELL President, CEO Nov 20 '24 Sale 6.65 50,000 332,295 722,747 Nov 20 07:57 PM JERRELL W SHELTON Director Nov 20 '24 Proposed Sale 6.93 100,000 693,500 Nov 20 04:33 PM JERRELL W SHELTON Director Nov 19 '24 Proposed Sale 6.70 50,000 335,000 Nov 19 04:30 PM JERRELL W SHELTON Director Nov 18 '24 Proposed Sale 6.99 50,000 349,500 Nov 18 05:14 PM Hariri Robert J Director Aug 19 '24 Sale 9.46 1,000 9,465 23,061 Aug 26 07:11 PM Hariri Robert J Director Aug 16 '24 Sale 9.00 1,000 9,000 23,561 Aug 20 05:28 PM Hariri Robert J Director Aug 14 '24 Sale 8.40 1,000 8,395 24,561 Aug 20 05:28 PM Mandalam Ramkumar Director Aug 02 '24 Option Exercise 5.04 4,167 21,002 60,199 Aug 06 08:00 PM Mandalam Ramkumar Director Aug 02 '24 Sale 8.04 4,167 33,520 56,032 Aug 06 08:00 PM RAMKUMAR MANDALAM Director Aug 02 '24 Proposed Sale 8.70 4,167 36,253 Aug 02 04:22 PM BERMAN RICHARD J Director May 15 '24 Sale 13.41 8,105 108,693 100,000 May 16 05:30 PM ZECCHINI EDWARD J Chief Digital and Tech Officer May 14 '24 Sale 13.37 3,443 46,042 60,051 May 15 07:28 PM STEFANOVICH ROBERT Chief Financial Officer Mar 25 '24 Sale 17.54 1,079 18,928 128,333 Mar 26 08:12 PM SHELTON JERRELL Chief Executive Officer Mar 25 '24 Sale 17.54 2,631 46,154 692,182 Mar 26 08:09 PM Sawicki Mark W Chief Scientific Officer Mar 25 '24 Sale 17.54 1,367 23,980 77,444 Mar 26 08:08 PM STEFANOVICH ROBERT Chief Financial Officer Mar 09 '24 Option Exercise 0.00 2,666 0 125,816 Mar 19 07:51 PM STEFANOVICH ROBERT Chief Financial Officer Mar 11 '24 Sale 16.35 1,119 18,298 124,697 Mar 19 07:51 PM STEFANOVICH ROBERT Chief Financial Officer Mar 15 '24 Sale 15.43 1,035 15,972 123,662 Mar 19 07:51 PM Sawicki Mark W Chief Scientific Officer Mar 09 '24 Option Exercise 0.00 2,666 0 75,791 Mar 19 07:50 PM Sawicki Mark W Chief Scientific Officer Mar 11 '24 Sale 16.35 1,418 23,188 74,373 Mar 19 07:50 PM Sawicki Mark W Chief Scientific Officer Mar 15 '24 Sale 15.43 1,312 20,247 73,061 Mar 19 07:50 PM Mandalam Ramkumar Director Mar 15 '24 Option Exercise 5.40 8,334 45,004 46,404 Mar 19 07:49 PM Mandalam Ramkumar Director Mar 15 '24 Sale 14.68 3,217 47,226 43,187 Mar 19 07:49 PM BADDOUR LINDA Director Mar 15 '24 Option Exercise 0.00 1,111 0 21,690 Mar 19 07:48 PM SHELTON JERRELL President, CEO Mar 15 '24 Option Exercise 4.80 100,000 480,000 749,253 Mar 19 07:48 PM SHELTON JERRELL President, CEO Mar 09 '24 Option Exercise 0.00 8,250 0 640,674 Mar 19 07:48 PM SHELTON JERRELL President, CEO Mar 15 '24 Sale 15.30 57,039 872,884 634,352 Mar 19 07:48 PM SHELTON JERRELL President, CEO Mar 11 '24 Sale 16.35 3,723 60,880 636,951 Mar 19 07:48 PM Hariri Robert J Director Dec 14 '23 Sale 16.89 800 13,512 12,716 Dec 18 07:19 PM Hariri Robert J Director Dec 11 '23 Sale 15.50 1,000 15,500 13,516 Dec 13 06:02 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite